Ji_2021_Br.J.Clin.Pharmacol_87_2247

Reference

Title : The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation - Ji_2021_Br.J.Clin.Pharmacol_87_2247
Author(s) : Ji Q , Zhang C , Xu Q , Wang Z , Li X , Lv Q
Ref : British Journal of Clinical Pharmacology , 87 :2247 , 2021
Abstract : Ji_2021_Br.J.Clin.Pharmacol_87_2247
ESTHER : Ji_2021_Br.J.Clin.Pharmacol_87_2247
PubMedSearch : Ji_2021_Br.J.Clin.Pharmacol_87_2247
PubMedID: 33179295

Related information

Citations formats

Ji Q, Zhang C, Xu Q, Wang Z, Li X, Lv Q (2021)
The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation
British Journal of Clinical Pharmacology 87 :2247

Ji Q, Zhang C, Xu Q, Wang Z, Li X, Lv Q (2021)
British Journal of Clinical Pharmacology 87 :2247